SCHEMBL23840470

SCHEMBL23840470

COc1ncc(NC(=O)c2cncn2C)cc1S(=O)(=O)Nc1c(C)cccc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 3/20 0.41
WDR77 Q9BQA1 3/20 0.41
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
MAPT P10636 4/20 0.39
LMNA P02545 3/20 0.39
ALDH1A1 P00352 3/20 0.39
HPGD P15428 1/20 0.39
HIF1A Q16665 1/20 0.39
PIK3C3 Q8NEB9 2/20 0.39
RAB9A P51151 1/20 0.37
ALPL P05186 3/20 0.36
BRAF P15056 1/20 0.36
POLB P06746 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MITF O75030 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
IDH1 O75874 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23840439 0.88 ROCK2 (0.40) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL23840635 0.88 POLB (0.42) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL25485987 0.87 MEN1 (0.46) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL23840436 0.86 MEN1 (0.45) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL23840344 0.85 PIK3C3 (0.39) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL23840544 0.85 ALDH1A1 (0.47) PRMT5WDR77MEN1KMT2AMAPT
SCHEMBL23840331 0.84 ALDH1A1 (0.50) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL25485956 0.84 NAMPT (0.52) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL23840611 0.83 NAMPT (0.49) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL23840446 0.82 POLB (0.48) MEN1KMT2AMAPTLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159509-A1 PYRIDINESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-05-25 US disclosed
WO-2021188907-A1 PYRIDINESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2021-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159509-A1 PYRIDINESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF TRAP1, PINK1, PPM1D PRMT5 4178/4885WDR77 3870/4885MEN1 3610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.